Dr. Gregory Vidal is co-leading a groundbreaking study aimed at identifying barriers to health care for Black women in the Mid-South. This initiative, supported by a $1.58 million grant from Gilead Sciences, Inc., is a collaborative effort with Dr. Janeane Anderson from the University of Tennessee Health Science Center’s College of Nursing. This research seeks… Read more »
Posts Tagged: clinical research
Treatment Option Videos
The Latest in Lung Cancer Research with Dr. Jason Porter
Tuesday, September 19 at 5pm EST Join Dr. Jason Porter for a live, dynamic discussion about the critical role of biomarker testing and clinical trials in lung cancer! Dr. Porter will partner with Estelamari Rodriguez, MD, MPH from the University of Miami’s Sylvester Comprehensive Cancer Center and moderator Terric Conneran, Founder of KRAS Kickers, to… Read more »
An examination of health care utilization during the COVID-19 pandemic among women with early-stage hormone receptor-positive breast cancer
“Women undergoing treatment for breast cancer require frequent clinic visits for maintenance of therapy. With COVID-19 causing health care disruptions, it is important to learn about how this population’s access to health care has changed.” The study linked below was co-authored by two of our very own – Dr. Gregory Vidal and Andrea Curry, and compares self-reported… Read more »
Cancer Watch: Clinical Trial with 100% Response Rate
We have advanced by leaps and bounds in our collective fight against cancer over the last several years. Because of #ClinicalResearch, patients around the world can benefit from new treatments offering improved efficiency, less negative sides effects, and increased survivorship rates. We are so excited to share that an amazing new trial for malignant skin… Read more »
Breast Cancer Disparities with Dr. Greg Vidal
The West Cancer Foundation recently sat down with Dr. Greg Vidal to talk about #breastcancer disparities. A 2014 study funded by the AVON Foundation discovered that Memphis had the highest national rate of breast cancer disparities among black women. They were dying of breast cancer at two times the rate of white women. Since this… Read more »
Reversing resistance to PD-1 inhibitors with combination immunotherapy in patients with advanced melanoma
West Cancer Center & Research Institute’s Ari Vanderwalde, MD, MPH is a SWOG (a National Cancer Institute supported organization that conducts clinical trials in adults) investigator and study chair for a trial that addresses advanced melanoma patients who are resistant to PD-1 inhibitors. Over 40% of these patients don’t respond to PD-1 inhibitors, widely used… Read more »
New MRI-Guided Brachytherapy Technique for Cervical Cancer
According to the American Cancer Society, more than 14,000 women are expected to be diagnosed with invasive cervical cancer in 2022 with an estimated 4,280 deaths. Cervical cancer was once one of the most common causes of cancer deaths for American women, but early detection from pap smears, HPV vaccines, and new innovative… Read more »
New Breast Conservation Surgery Clinical Trial
Perimeter Medical Imaging AI Announces Initiation of First Clinical Trial Site at West Cancer Center & Research Institute in Tennessee Pivotal study to determine the impact of Perimeter B-Series OCT with ImgAssist AI on positive margin rates during breast conservation surgery Perimeter Medical Imaging AI, Inc., a medical technology company driven to transform cancer surgery… Read more »
Dr. Noam VanderWalde Publishes Study on Disparities in Older Adults
Dr. Noam VanderWalde, one of our incredible Radiation Oncologists here at West, is extremely passionate about geriatric oncology care. Below is a link to his most recent cooperative group publication, entitled “Disparities in older adult accrual to cancer trials: Analysis from the alliance for clinical trials in oncology (A151736).” Click the link below to read… Read more »